Single-Cell Multiomics Analysis for Drug Discovery
Given the heterogeneity seen in cell populations within biological systems, analysis of single cells is necessary for studying mechanisms that cannot be identified on a bulk population level. There are significant variations in the biological and physiological function of cell populations due to the...
Guardado en:
Autores principales: | , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/49983e110db8453e949658b83450a736 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:49983e110db8453e949658b83450a736 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:49983e110db8453e949658b83450a7362021-11-25T18:20:30ZSingle-Cell Multiomics Analysis for Drug Discovery10.3390/metabo111107292218-1989https://doaj.org/article/49983e110db8453e949658b83450a7362021-10-01T00:00:00Zhttps://www.mdpi.com/2218-1989/11/11/729https://doaj.org/toc/2218-1989Given the heterogeneity seen in cell populations within biological systems, analysis of single cells is necessary for studying mechanisms that cannot be identified on a bulk population level. There are significant variations in the biological and physiological function of cell populations due to the functional differences within, as well as between, single species as a result of the specific proteome, transcriptome, and metabolome that are unique to each individual cell. Single-cell analysis proves crucial in providing a comprehensive understanding of the biological and physiological properties underlying human health and disease. Omics technologies can help to examine proteins (proteomics), RNA molecules (transcriptomics), and the chemical processes involving metabolites (metabolomics) in cells, in addition to genomes. In this review, we discuss the value of multiomics in drug discovery and the importance of single-cell multiomics measurements. We will provide examples of the benefits of applying single-cell omics technologies in drug discovery and development. Moreover, we intend to show how multiomics offers the opportunity to understand the detailed events which produce or prevent disease, and ways in which the separate omics disciplines complement each other to build a broader, deeper knowledge base.Sam F. NassarKhadir RaddassiTerence WuMDPI AGarticlemultiomicsgenomicsmetabolomicsproteomicstranscriptomicssingle-cellMicrobiologyQR1-502ENMetabolites, Vol 11, Iss 729, p 729 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
multiomics genomics metabolomics proteomics transcriptomics single-cell Microbiology QR1-502 |
spellingShingle |
multiomics genomics metabolomics proteomics transcriptomics single-cell Microbiology QR1-502 Sam F. Nassar Khadir Raddassi Terence Wu Single-Cell Multiomics Analysis for Drug Discovery |
description |
Given the heterogeneity seen in cell populations within biological systems, analysis of single cells is necessary for studying mechanisms that cannot be identified on a bulk population level. There are significant variations in the biological and physiological function of cell populations due to the functional differences within, as well as between, single species as a result of the specific proteome, transcriptome, and metabolome that are unique to each individual cell. Single-cell analysis proves crucial in providing a comprehensive understanding of the biological and physiological properties underlying human health and disease. Omics technologies can help to examine proteins (proteomics), RNA molecules (transcriptomics), and the chemical processes involving metabolites (metabolomics) in cells, in addition to genomes. In this review, we discuss the value of multiomics in drug discovery and the importance of single-cell multiomics measurements. We will provide examples of the benefits of applying single-cell omics technologies in drug discovery and development. Moreover, we intend to show how multiomics offers the opportunity to understand the detailed events which produce or prevent disease, and ways in which the separate omics disciplines complement each other to build a broader, deeper knowledge base. |
format |
article |
author |
Sam F. Nassar Khadir Raddassi Terence Wu |
author_facet |
Sam F. Nassar Khadir Raddassi Terence Wu |
author_sort |
Sam F. Nassar |
title |
Single-Cell Multiomics Analysis for Drug Discovery |
title_short |
Single-Cell Multiomics Analysis for Drug Discovery |
title_full |
Single-Cell Multiomics Analysis for Drug Discovery |
title_fullStr |
Single-Cell Multiomics Analysis for Drug Discovery |
title_full_unstemmed |
Single-Cell Multiomics Analysis for Drug Discovery |
title_sort |
single-cell multiomics analysis for drug discovery |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/49983e110db8453e949658b83450a736 |
work_keys_str_mv |
AT samfnassar singlecellmultiomicsanalysisfordrugdiscovery AT khadirraddassi singlecellmultiomicsanalysisfordrugdiscovery AT terencewu singlecellmultiomicsanalysisfordrugdiscovery |
_version_ |
1718411317348401152 |